Sleep hormone trial offers hope for new moms with heart failure

NCT ID NCT07334197

Summary

This study is testing whether adding melatonin, a natural hormone, to standard heart failure treatment helps women recover from peripartum cardiomyopathy—a rare but serious heart condition that can occur around childbirth. Researchers will measure if melatonin improves heart function, reduces inflammation, and helps women walk farther. The trial involves 25 women who will receive either standard treatment alone or standard treatment plus melatonin for three months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PPM, CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

Explore the condition pages connected to this study.